Royalty Pharma plc logo RPRX - Royalty Pharma plc

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 11
HOLD 0
SELL 0
STRONG
SELL
0
| PRICE TARGET: $53.75 DETAILS
HIGH: $63.00
LOW: $45.00
MEDIAN: $53.50
CONSENSUS: $53.75
DOWNSIDE: 1.38%
AlphaQuality

AlphaQuality

Quantitative six-pillar business-quality grade

Stable Earnings Power

AlphaQuality — archetype-weighted quantitative grade

C 51.2 / 100 composite

Composite Grade

Composite of six pillars weighted for stable earnings power businesses. Purely quantitative — no stock price or analyst input.

Profitability

Weight: 20%
C+ 61.7
  • 5yr Avg ROIC 7.1% 45/100
  • Operating Margin Trend +4.95 pp/yr 100/100
Contributes 12.3 pts toward composite.

Capital Efficiency

Weight: 15%
D+ 40.9
  • 5yr Avg ROE 10.6% 63/100
  • 5yr Share-Count CAGR 7.8% 0/100
Contributes 6.1 pts toward composite.

Growth Quality

Weight: 15%
D+ 43.4
  • 5yr Revenue CAGR 1.0% 28/100
  • 5yr EPS CAGR 4.8% 54/100
  • Revenue-Growth Years (5) 3/5 60/100
Contributes 6.5 pts toward composite.

Cash Generation

Weight: 15%
A- 84.2
  • 5yr FCF Margin 107.6% 100/100
  • 5yr FCF/NI Conversion 12.48x 65/100
Contributes 12.6 pts toward composite.

Balance Sheet

Weight: 20%
D 37.0
  • Net Debt / EBITDA 5.08x 14/100
  • Interest Coverage (EBIT/Int) 5.30x 66/100
  • Altman Z-Score 2.05 43/100
Contributes 7.4 pts toward composite.

Stability

Weight: 15%
D+ 41.9
  • EPS Volatility (σ/μ) 0.80 8/100
  • Piotroski F-Score 7 78/100
  • Negative-Revenue Years (5) 2/5 60/100
Contributes 6.3 pts toward composite.

Guru Flow

Curated superinvestor sentiment — not part of the AlphaQuality grade.
Holding

2 of 2 gurus held; 1 added; 1 trimmed.

Holders
2
Avg Δ position
+12.8%
New buys
0
Full exits
0
As of Q1 2026
How this is calculated

AlphaQuality grades six pillars from 0-100 and weights each by archetype:

  • Profitability (20%) — 5yr Avg ROIC, Operating Margin Trend
  • Capital Efficiency (15%) — 5yr Avg ROE, 5yr Share-Count CAGR
  • Growth Quality (15%) — 5yr Revenue CAGR, 5yr EPS CAGR, Revenue-Growth Years (5)
  • Cash Generation (15%) — 5yr FCF Margin, 5yr FCF/NI Conversion
  • Balance Sheet (20%) — Net Debt / EBITDA, Interest Coverage (EBIT/Int), Altman Z-Score
  • Stability (15%) — EPS Volatility (σ/μ), Piotroski F-Score, Negative-Revenue Years (5)

We deliberately ignore stock price, analyst targets, and consensus ratings so the grade is suitable for backtesting forward returns. A minimum of 5 fiscal years of audited statements is required; distressed and highly leveraged infrastructure businesses are declared ungradable rather than forced into a numeric score.